PF
GLMD icon

Phoenix Financial’s Galmed Pharmaceuticals GLMD Stock Holding History

Phoenix Financial’s Portfolio GLMD Stock Details GLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-810
Closed -$480K – 389
2020
Q3 		$480K Buy
810
+63
+8% +$51.4K 0.02% 232
2020
Q2 		$611K Buy
747
+328
+78% +$277K 0.03% 231
2020
Q1 		$253K Buy
419
+318
+315% +$302K 0.01% 279
2019
Q4 		$105K Sell
101
-39
-28% -$33.5K ﹤0.01% 193
2019
Q3 		$115K Buy
+140
New +$140K 0.01% 187

Other funds holding GLMD

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
PAWC
P.A.W. Capital Greenwich, Connecticut $88.2M AUM 25.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Phoenix Financial's GLMD Position: Q4 2020 in Review

Phoenix Financial sold out of Galmed Pharmaceuticals (GLMD) in Q4 2020, closing a stake of 810 shares — an estimated $480K sold.

Phoenix Financial first reported a position in GLMD in Q3 2019 and held it in 5 quarters. The position peaked at $611K in Q2 2020. 21 funds tracked by Wall St. Rank hold GLMD as of Q4 2020.

  • Phoenix Financial reported no remaining Galmed Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Phoenix Financial sold 810 Galmed Pharmaceuticals shares in Q4 2020, an estimated $480K.
  • Phoenix Financial first reported a position in Galmed Pharmaceuticals in Q3 2019 and held it in 5 quarters.
  • Phoenix Financial's Galmed Pharmaceuticals position peaked at $611K in Q2 2020.
  • 21 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q4 2020.

Based on Phoenix Financial's 13F filing for Q4 2020, filed 11 Feb 2021.